Olink Proteomics

Olink Proteomics AB, founded in 2004 and headquartered in Uppsala, Sweden, specializes in human protein biomarker discovery through its proprietary Proximity Extension Assay technology. The company offers a range of products, including multiplex immunoassay panels that facilitate the identification of multiple proteins for disease detection and research decision-making. Its diverse panels address various health conditions, such as cardiovascular diseases, neurology, inflammation, and oncology, allowing for the analysis of both low- and high-abundance biomarkers. Olink also provides specialized panels for murine protein discovery and organ damage assessment. In addition to its product offerings, the company supports researchers with the NPX Manager software for efficient panel management. Olink generates revenue from multiple regions, including Sweden, the United States, China, and EMEA countries, leveraging its established lab infrastructure for both research and clinical applications.